# Top 50 Biotechnology VC (Venture Capital) Funds in United States in June 2026

| Investor | Relevant Deals | Geography | Stage | Focus |
| --- | --- | --- | --- | --- |
| SOSV | 124 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software |
| ARCH Venture Partners | 121 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Alexandria Venture Investments | 99 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics |
| OrbiMed | 84 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| Atlas Venture | 73 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| New Enterprise Associates | 68 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology |
| Versant Ventures | 66 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Polaris Partners | 63 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| Innova Memphis | 63 | United States, Argentina, United Kingdom | Seed, Pre-Seed | Health Care, Medical, Medical Device |
| Khosla Ventures | 62 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care |
| Third Rock Ventures | 62 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| 5AM Ventures | 62 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| MPM Capital | 60 | United States, Canada, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| RA Capital Management | 58 | United States, United Kingdom, Canada | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Therapeutics |
| F-Prime | 56 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical |
| Alumni Ventures | 52 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology |
| Canaan Partners | 50 | United States, United Kingdom, Israel | Series A, Series B, Series C | Software, Biotechnology, Health Care |
| BioAdvance | 48 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical |
| Andreessen Horowitz | 47 | United States, United Kingdom, Brazil | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence |
| The Column Group | 46 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Google Ventures | 45 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology |
| KdT Ventures | 45 | United States, India, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Medical |
| Novartis Venture Fund | 43 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Lux Capital | 43 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care |
| Connecticut Innovations | 42 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software |
| Fifty Years | 41 | United States, Germany, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Artificial Intelligence |
| DCVC | 41 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning |
| Mission BioCapital | 41 | United States, Switzerland, France | Series A, Series B | Biotechnology, Health Care, Therapeutics |
| Gaingels | 40 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence |
| Dolby Family Ventures | 40 | United States, Austria, Germany | Series A, Seed, Series B | Biotechnology, Health Care, Therapeutics |
| Hatteras Venture Partners | 39 | United States, Canada | Series A, Series B, Series C | Health Care, Biotechnology, Medical |
| Frazier Healthcare Partners | 38 | United States, Canada, Ireland | Series B, Series A, Post-IPO Equity | Biotechnology, Health Care, Therapeutics |
| Northpond Ventures | 37 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Life Science |
| Sofinnova Investments | 37 | United States, France, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Pfizer Venture Investments | 37 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Civilization Ventures | 37 | United States, United Kingdom, Brazil | Seed, Series A, Series B | Biotechnology, Health Care, Medical |
| Novo Holdings | 37 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Omega Funds | 36 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Founders Fund | 35 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Health Care, Information Technology |
| Boston Harbor Angels | 35 | United States, Canada, India | Angel, Seed, Series A | Biotechnology, Health Care, Medical Device |
| Life Science Angels | 35 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical |
| Illumina Ventures | 34 | United States, United Kingdom, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Flagship Pioneering | 33 | United States, Canada, United Kingdom | Series B, Series C, Series A | Biotechnology, Health Care, Medical |
| Domain Associates | 33 | United States, Canada, Estonia | Series B, Series C, Series A | Biotechnology, Health Care, Medical |
| Refactor | 33 | United States, United Kingdom, New Zealand | Seed, Series A, Series B | Health Care, Biotechnology, Medical |
| Amgen Ventures | 33 | United States, Canada, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| SR One | 32 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| North Carolina Biotechnology Center | 31 | United States, United Kingdom | Debt Financing, Grant | Biotechnology, Health Care, Medical |
| Vivo Capital | 31 | United States, China, United Kingdom | Post-IPO Equity, Series B, Series C | Biotechnology, Health Care, Pharmaceutical |
| Eli Lilly | 31 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Medical |

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co